DRUGS AND DEVICES  


NRS 585.370. Adulterated drugs and devices: Poisonous or insanitary ingredients.
NRS 585.380. Adulterated drugs and devices: Strength, quality or purity differing from official compendium.
NRS 585.390. Adulterated drugs and devices: Misrepresentation of strength, quality or purity if drug not in compendium.
NRS 585.400. Adulterated drugs and devices: Mixture with or substitution of another substance.
NRS 585.410. Misbranded drugs and devices: False or misleading label.
NRS 585.420. Misbranded drugs and devices: Contents of label on package.
NRS 585.430. Misbranded drugs and devices: Habit-forming substances.
NRS 585.440. Misbranded drugs and devices: Designation of drug by name not in compendium.
NRS 585.450. Misbranded drugs and devices: Directions for use and warnings on label.
NRS 585.460. Misbranded drugs and devices: Misleading container; imitation; offer for sale under another name.
NRS 585.470. Misbranded drugs and devices: Health-endangering when used as prescribed.
NRS 585.480. Misbranded drugs and devices: Drug containing amidopyrine, barbituric acid, cinchophen, dinitrophenol or sulfanilamide sold without prescription.
NRS 585.485. Restrictions on sale of dimethyl sulfoxide; penalty.
NRS 585.490. Introduction or delivery for introduction of new drug into intrastate commerce before application is effective prohibited.
NRS 585.495. Licensing of manufacture of amygdalin and procaine hydrochloride; duties and powers of Commissioner; injunctive relief.
NRS 585.497. Assessment on gross receipts from sale of amygdalin and procaine hydrochloride.